These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27058333)

  • 21. Effect of influenza vaccination on disease progression among HIV-infected persons.
    Sullivan PS; Hanson DL; Dworkin MS; Jones JL; Ward JW;
    AIDS; 2000 Dec; 14(17):2781-5. PubMed ID: 11125897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender-specific differences in the natural history, clinical features, and socioeconomic status of HIV-infected patients: experience of a treatment centre in Vienna.
    Armbruster C; Kriwanek S; Vorbach H
    Wien Klin Wochenschr; 2000 Sep; 112(17):754-60. PubMed ID: 11042904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic accuracy of three clinical case definitions for advanced HIV disease.
    Gallant JE; Somani J; Chaisson RE; Stanton D; Smith M; Quinn TC
    AIDS; 1992 Mar; 6(3):295-9. PubMed ID: 1348946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV and AIDS in the European Union, 2009.
    Likatavicius G; Van de Laar MJ
    Euro Surveill; 2010 Dec; 15(48):. PubMed ID: 21144450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Characteristics of newly reported HIV/AIDS cases in Henan province, 2010-2018].
    Liang Y; Li N; Sun DY; Fan PY; Yang WJ; Nie YG; Wang Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Apr; 41(4):532-536. PubMed ID: 32344477
    [No Abstract]   [Full Text] [Related]  

  • 26. [Study on factors associated with heterosexual-transmission of human immunodeficiency virus in central China].
    Li L; Li JY; Bao ZY; Liu SY; Zhuang DM; Liu YJ; Feng FM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Nov; 24(11):980-3. PubMed ID: 14687496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of clinical manifestations of HIV infection among women by risk group, CD4+ cell count, and HIV-1 plasma viral load. HER Study Group. HIV Epidemiology Research.
    Rompalo AM; Astemborski J; Schoenbaum E; Schuman P; Carpenter C; Holmberg SD; Warren DL; Farzadegan H; Vlahov D; Smith DK
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Apr; 20(5):448-54. PubMed ID: 10225226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The values of quantitative serum HIV-1 RNA levels and CD4 cell counts for predicting survival time among HIV-positive individuals with CD4 counts of < or = 50 x 10(6) cells/l.
    Coakley EP; Samore MH; Gillis JM; Hughes MD; Hammer SM
    AIDS; 2000 Jun; 14(9):1147-53. PubMed ID: 10894278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA).
    AIDS; 1998 Mar; 12(4):F1-8. PubMed ID: 9520161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [APOBEC3 hypermutations in HIV-1 infected cases in Turkey].
    Sayan M; Simşek F; Ceran N; Dokuzoğuz B; Eraksoy H
    Mikrobiyol Bul; 2013 Jul; 47(3):482-92. PubMed ID: 23971925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of maintaining highly active antiretroviral therapy on AIDS events among patients with late-stage HIV infection and inadequate response to therapy.
    Gandhi T; Wei W; Amin K; Kazanjian P
    Clin Infect Dis; 2006 Mar; 42(6):878-84. PubMed ID: 16477568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of prognostic importance of latest CD4+ cell count and HIV RNA levels in patients with advanced HIV infection on highly active antiretroviral therapy.
    MacArthur RD; Perez G; Walmsley S; Baxter JD; Mullin CM; Neaton JD; ;
    HIV Clin Trials; 2005; 6(3):127-35. PubMed ID: 16192247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Making the invisible, visible: a cross-sectional study of late presentation to HIV/AIDS services among men who have sex with men from a large urban center of Brazil.
    MacCarthy S; Brignol S; Reddy M; Nunn A; Dourado I
    BMC Public Health; 2014 Dec; 14():1313. PubMed ID: 25535408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Both serum HIV type 1 RNA levels and CD4+ lymphocyte counts predict clinical outcome in HIV type 1-infected subjects with 200 to 500 CD4+ cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team.
    Kim S; Hughes MD; Hammer SM; Jackson JB; DeGruttola V; Katzenstein DA
    AIDS Res Hum Retroviruses; 2000 May; 16(7):645-53. PubMed ID: 10791875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of CD4 count, CD4% and HIV viral load with clinical manifestations of HIV in infected Indian children.
    Shah I
    Ann Trop Paediatr; 2006 Jun; 26(2):115-9. PubMed ID: 16709329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS.
    O'Brien WA; Hartigan PM; Daar ES; Simberkoff MS; Hamilton JD
    Ann Intern Med; 1997 Jun; 126(12):939-45. PubMed ID: 9182470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV and AIDS in Poland in 2012.
    Niedźwiedzka-Stadnik M; Pielacha M; Rosińska M
    Przegl Epidemiol; 2014; 68(2):283-9, 383-6. PubMed ID: 25135516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mucocutaneous manifestations and the relationship to CD4 lymphocyte counts among Turkish HIV/AIDS patients in Istanbul, Turkey.
    Altuntaş Aydin Ö; Kumbasar Karaosmanoğlu H; Korkusuz R; Özeren M; Özcan N
    Turk J Med Sci; 2015; 45(1):89-92. PubMed ID: 25790535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in HIV-1 viral loads between male and female antiretroviral-untreated Mexican patients.
    Ballesteros-Zebadúa P; Villarreal C; Cocho G; Huerta L; Estrada JL
    Arch Med Res; 2013 May; 44(4):296-301. PubMed ID: 23608673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection. The SEROCO Study Group.
    Hubert JB; Burgard M; Dussaix E; Tamalet C; Deveau C; Le Chenadec J; Chaix ML; Marchadier E; Vildé JL; Delfraissy JF; Meyer L; Rouzioux
    AIDS; 2000 Jan; 14(2):123-31. PubMed ID: 10708282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.